Methyl 3-bromo-1H-indazole-6-carboxylate

CAS: 192945-56-5

Ref. 3D-SHA94556

Produktinformation

• Name: Methyl 3-bromo-1H-indazole-6-carboxylate
• Synonyme: 1H-Indazole-6-carboxylic acid, 3-bromo-, methyl ester, Methyl 3-bromoindazole-6-carboxylate

Beschreibung

Methyl 3-bromo-1H-indazole-6-carboxylate is a bile acid homeostasis activator that belongs to the class of small molecules. It has been shown to have anti-inflammatory and antiobesity effects, which are mediated by the activation of peroxisome proliferator activated receptor alpha. Methyl 3-bromo-1H-indazole-6-carboxylate has also been shown to be effective in reducing nonalcoholic steatohepatitis (NASH) in a mouse model and is being developed as a treatment for NASH. The drug is currently under development by Janssen and is currently in Phase 1 clinical trials.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 255.07 g/mol
• Formel: C₉H₇BrN₂O₂
• Reinheit: Min. 95%